Alliance Pharma plc announced that Peter Butterfield, Chief Executive Officer, is taking time away from the business for personal reasons. He is expected to return during January 2023. Andrew Franklin, Chief Financial Officer, has assumed Peter's CEO responsibilities, in line with the Group's established resilience plans, with support from the Head of Finance and the wider leadership team.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.1 GBX | -4.62% | -10.23% | -13.33% |
30/05 | Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies | CI |
21/05 | Alliance Pharma plc Announces the Appointment of Nicholas John Sedgwick as Director | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.33% | 243M | |
+17.86% | 42.33B | |
+21.86% | 22.47B | |
+16.96% | 15.25B | |
+19.15% | 14.29B | |
+52.65% | 12.6B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.27% | 5.47B |
- Stock Market
- Equities
- APH Stock
- News Alliance Pharma plc
- Alliance Pharma plc Announces CEO Changes